https://scholars.duke.edu/publication/1412036
Scholars@Duke publication: Vorapaxar in the secondary prevention of atherothrombotic events.
in thesecondary preventionscholarsdukepublication
https://blogs.bmj.com/heart/2011/12/01/vorapaxar-fails-to-improve-outcomes/
Vorapaxar fails to improve outcomes - Heart
Nov 12, 2015 - Thrombin is a key component in the coagulation cascade, cleaving fibrinogen to form insoluble fibrin, and also acting as a potent platelet activator through...
improve outcomesfailsheart
https://pubchem.ncbi.nlm.nih.gov/compound/24830431
Vorapaxar metabolite M16 | C29H31FN2O6 | CID 24830431 - PubChem
Vorapaxar metabolite M16 | C29H31FN2O6 | CID 24830431 - structure, chemical names, physical and chemical properties, classification, patents, literature,...
metabolitecidpubchem